Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Current Pharmaceutical Design
|
February 23, 2005
Antiangiogenic agents: studies on fumagillin and curcumin analogs
M S Furness, T P Robinson, T Ehlers, et al.
The American Journal of Pathology
|
December 7, 2000
Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells
K R LaMontagne, M A Moses, D Wiederschain, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 26, 2000
Curcumin is an in vivo inhibitor of angiogenesis
J L Arbiser, N Klauber, R Rohan, et al.
Journal of the American Academy of Dermatology
|
October 19, 2001
Are keloids really "gli-loids"?: High-level expression of gli-1 oncogene in keloids
A Kim, J DiCarlo, C Cohen, et al.
The Journal of Clinical Investigation
|
December 1, 1994
Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes
M B Goldring, J R Birkhead, L F Suen, et al.
The American Journal of Pathology
|
April 7, 2000
Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo
J L Arbiser, H Larsson, L Claesson-Welsh, et al.
The British Journal of Dermatology
|
July 28, 2011
Transgrediens pachyonychia congenita (PC): case series of a nonclassical PC presentation
K Harris, P R Hull, C D Hansen, et al.
The American Journal of Pathology
|
September 17, 1999
Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity
J L Arbiser, G Raab, R M Rohan, et al.
Journal of the American Academy of Dermatology
|
February 15, 2001
Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy
J L Arbiser, S W Weiss, Z K Arbiser, et al.
Molecular Medicine (Cambridge, Mass.)
|
December 16, 1998
Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy
J L Arbiser, S K Kraeft, R van Leeuwen, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Current Pharmaceutical Design
|
February 23, 2005
Antiangiogenic agents: studies on fumagillin and curcumin analogs
M S Furness, T P Robinson, T Ehlers, et al.
The American Journal of Pathology
|
December 7, 2000
Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells
K R LaMontagne, M A Moses, D Wiederschain, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 26, 2000
Curcumin is an in vivo inhibitor of angiogenesis
J L Arbiser, N Klauber, R Rohan, et al.
Journal of the American Academy of Dermatology
|
October 19, 2001
Are keloids really "gli-loids"?: High-level expression of gli-1 oncogene in keloids
A Kim, J DiCarlo, C Cohen, et al.
The Journal of Clinical Investigation
|
December 1, 1994
Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes
M B Goldring, J R Birkhead, L F Suen, et al.
The American Journal of Pathology
|
April 7, 2000
Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo
J L Arbiser, H Larsson, L Claesson-Welsh, et al.
The British Journal of Dermatology
|
July 28, 2011
Transgrediens pachyonychia congenita (PC): case series of a nonclassical PC presentation
K Harris, P R Hull, C D Hansen, et al.
The American Journal of Pathology
|
September 17, 1999
Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity
J L Arbiser, G Raab, R M Rohan, et al.
Journal of the American Academy of Dermatology
|
February 15, 2001
Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy
J L Arbiser, S W Weiss, Z K Arbiser, et al.
Molecular Medicine (Cambridge, Mass.)
|
December 16, 1998
Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy
J L Arbiser, S K Kraeft, R van Leeuwen, et al.
Page
of 5